Does Proton Pump Inhibitor Increase the Clostridium difficile Infection Risk in the Treatment and Prophylaxis of Stress Ulcers than Histanime-2 Receptor Antagonist?

참고문헌 (9)

1. Alhazzani W, "Proton pump inhibitors versus histamine 2 receptor antagonists for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis", Crit Care Med, 41, pp.693~705 (2013)
2. Krag M, "Stress ulcer prophylaxis versus placebo or no prophylaxis in critically ill patients: a systematic review of randomised clinical trials with meta-analysis and trial sequential analysis", Intensive Care Med, 40, pp.11~22 (2014)
3. Farley KJ, "Inappropriate continuation of stress ulcer prophylaxis beyond the intensive care setting", Crit Care Resusc, 15, pp.147~151 (2013)
4. Zink DA, "Long-term use of acid suppression started inappropriately during hospitalization", Aliment Pharmacol Ther, 21, pp.1203~1209 (2005)
5. Tleyjeh IM, "The association between histamine 2 receptor antagonist use and Clostridium difficile infection: a systematic review and meta-analysis", PLoS One, 8, pp.e56498~ (2013)
6. Kwok CS, "Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis", Am J Gastroenterol, 107, pp.1011~1019 (2012)
7. Janarthanan S, "Clostridium difficile-associated diarrhea and proton pump inhibitor therapy: a meta-analysis", Am J Gastroenterol, 107, pp.1001~1010 (2012)
8. Deshpande A, "Association between proton pump inhibitor therapy and Clostridium difficile infection in a meta-analysis", Clin Gastroenterol Hepatol, 10, pp.225~233 (2012)
9. Mohamed Azab, "Comparison of the Hospital-Acquired Clostridium difficile Infection Risk of Using Proton Pump Inhibitors versus Histamine-2 Receptor Antagonists for Prophylaxis and Treatment of Stress Ulcers: A Systematic Review and Meta-Analysis", Gut and Liver, 11(6), pp.781~788 (2017), 거트앤리버 발행위원회

관련 논문AI추천